The Institute of Medicine (IOM) of the National Academy of Sciences, has designated CMV as a "highest priority" category for vaccine development, citing the years of life and disability that could be saved.Major Key Players of the Cytomegalovirus (CMV) Vaccines Market are:...
There is no availablevaccinefor preventing congenital CMV infection or CMV disease in individuals with suppressed immune systems. However, researchers are studying experimentalvaccinesin humans. It may be a number of years before there is a Food and Drug Administration (FDA)-approved CMV vaccine. ...